PNC Financial Services Group
CPXX

PNC Financial Services Group’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

PNC Financial Services Group’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,000
Closed -$37K – 4842
2015
Q1 		$37K Buy
+15,000
New +$40.4K ﹤0.01% 3205

Other funds holding CPXX

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

PNC Financial Services Group's CPXX Position: Q2 2015 in Review

PNC Financial Services Group sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q2 2015, closing a stake of 15,000 shares — an estimated $37K sold.

PNC Financial Services Group first reported a position in CPXX in Q1 2015 and held it in 1 quarter. The position peaked at $37K in Q1 2015. 16 funds tracked by Wall St. Rank hold CPXX as of Q2 2015.

  • PNC Financial Services Group reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • PNC Financial Services Group sold 15,000 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q2 2015, an estimated $37K.
  • PNC Financial Services Group first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2015 and held it in 1 quarter.
  • PNC Financial Services Group's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $37K in Q1 2015.
  • 16 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q2 2015.

Based on PNC Financial Services Group's 13F filing for Q2 2015, filed 5 Aug 2015.